Recent Headlines
Within Pharmaceuticals
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Hospice Home Care Expands to Cover All of Los Angeles County
Every city in Los Angeles Country will be serviced by Hospice Home Care. The department that has been created will allow doctors, nurses, volunteers and other hospice care professionals to service thousands of patients in the Los Angeles area. - August 08, 2022 - Hospice Home Care
Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing
The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo
Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances
Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext
Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists
NY Imaging Specialists announced today the appointments of Tim Wintz and Jarett Greenside to Senior Vice Presidents of Radiology. - August 02, 2022 - New York Imaging Specialists
Meridian Diagnostics Helps Healthcare Practices Make Better Decisions
Meridian Diagnostics is a clinical diagnostic reference laboratory based in Colorado and offers services to clinics, laboratories, employers and healthcare practices nationwide. Their aim is to assist healthcare providers with making informed decisions for their patients. Meridian realizes you have many options for laboratory services, but their 18-24 hour turn-around-time on all results from UTI, toxicology, blood, and various respiratory pathogens makes them the lab of choice for providers. - July 26, 2022 - Meridian Diagnostics
Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research
Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens for the detection of Monkeypox viruses. - July 22, 2022 - Creative Diagnostics
Creative Diagnostics Introduces New Cell-Based ELISA Services
Creative Diagnostics is offering comprehensive services for Cell-based ELISA that can measure the reduction of viral antigens in infected cells using anti-virus antibodies or compounds. - July 22, 2022 - Creative Diagnostics
Heartland Pharmacy Creates New Collaborative Care Program
Heartland Pharmacy is launching a new senior care program to promote collaborative care for advanced physical wellness. - July 21, 2022 - Heartland Pharmacy
International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals
A new peer-reviewed report by a panel of scientists sheds new light on regulation and management of per- and polyfluoroalkyl substances (PFAS). SciPinion, which objectively engages the global scientific community to analyze the toughest scientific topics, today announced the publication of an... - July 19, 2022 - SciPinion
Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance
Chad Price, CEO of Raleigh-based Mako Medical and Mako Medical Laboratories, announced the company is expanding its service throughout the state of Virginia by adding a new member to the laboratory Alliance. - July 18, 2022 - Mako Medical Laboratories
Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test
Chad Price, CEO of Mako Medical, recently announced his team has developed a monkeypox test. - July 18, 2022 - Mako Medical Laboratories
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network
Pharmacy Stars to launch the Sterile Compounding Quality Peer Network with the goal of filling the vacated role of CriticalPoint’s Peer Network, an online forum designed to support 503A entities, their regulators, and their certifiers. The CriticalPoint Peer Network has been discontinued as of June 30, 2022, according to the CriticalPoint website. - July 11, 2022 - Pharmacy Stars, LLC
ReproTech, LLC Welcomes New President & CEO, William Braun
ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC
Team Arnav Foundation to Hold 3rd Annual Event
Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation
River Valley Relief Names Ryan Kenaga President
River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Terrain Health Partners with Novel Biotech Company Microgenesis to Offer Breakthrough Solutions for Infertility
Terrain Health, an international precision healthcare organization partners with novel biotechnology, science research company Microgenesis, to offer a natural and effective solution to restore fertility potential by identifying root cause of infertility issues, now shown to be linked to the health of the gut microbiome. - July 06, 2022 - Terrain Health Inc.
Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext
Don't Let Joint Pain Hold You Back
Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health
NF Sports Releases New "Immune Defense(TM)" Drink Mix
Nutrition Supplement Company Aims to Combat Weakened Immune Systems by Helping to Limit the Spread of Viruses at the Cellular Level. - June 30, 2022 - NF Sports
Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization
The Verna J. Kirkness Education Foundation Board Chair, Tony Williams, plans to announce the Board’s decision to return the $500,000 endowment to the Sisters of Saint Anne and terminate the 4.5-year-long relationship. In his announcement, Tony Williams will explain his Board’s decision... - June 24, 2022 - Verna J. Kirkness Foundation
iTech Offers 60-Day Free Trial on expEDIum Medical Billing® Product
iTech, a leading Healthcare IT Solutions vendor specializing in delivering a secure, affordable, and comprehensive cloud-based Medical Billing & Practice Management Software, offers a 60-day free trial on their expEDIum Medical Billing® product. - June 24, 2022 - expEDIum
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
Defined Bioscience Announces Formation of Scientific Advisory Board
Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.
GENINVO Launches Its Latest Offering - Innovation as a Service
GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.
Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies
Creative Diagnostics announced the release of new measles virus antigens suitable for both IgM and IgG detection. - June 11, 2022 - Creative Diagnostics
Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety
Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy. - June 11, 2022 - Creative Diagnostics
HealthWare Systems Expands Services
HealthWare Systems meets evolving client needs with healthcare automation solutions, RPA, and services divisions – CredentialingOne & EligibilityAdvocates. - June 10, 2022 - HealthWare Systems
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home
Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
Period Tracking App, Femometer, Launches Discount and Offers in Celebration of 10 Million Users
Reproductive, period, and pregnancy tracking app, Femometer, is celebrating a milestone of 10 million users. Femometer is offering more than half-off the Prime Membership option, as well as select products purchased through the app. The celebratory discount will be available to users from the 1st of June to 8th of June. - May 31, 2022 - Lollipop Technology Hangzhou Ltd. Co.
Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics
aNUma, Inc., a digital therapeutics company building virtual reality programs to address the global mental health crisis, today, announced that Scientific Reports has published research demonstrating technology like that behind aNUma’s VR platform can deliver peak experiences, ego attenuation, and connectedness comparable to psychedelics. This study, written by Dr. David Glowacki and colleagues, is the first of its kind to be published in a leading peer-reviewed journal. - May 30, 2022 - aNUma
Creative Diagnostics Launches Antibody-Dependent Enhancement Assay Services
Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. - May 26, 2022 - Creative Diagnostics
Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests
Creative Diagnostics recently launched recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). - May 26, 2022 - Creative Diagnostics
Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase
Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute
Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program
Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners
Molekule Consulting Announces the Launch of E.U. - Based Operations
Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting
Baltimore Innovation Invited You to Come and Meet Them for Coffee
Baltimore Innovations staff was present at Pharmapack in Paris on the 18 May 2022. This show is a popular event for the pharmaceutical packaging industry, and a great way to get new ideas from all over the world. Baltimore Innovations’ Global Sales Director Philippe Depois was in attendance... - May 24, 2022 - Baltimore Innovation
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
NuvOx Pharma Announces Issuance of a New Patent
NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” - May 19, 2022 - NuvOx Pharma
North American Pet Insurance Market More Than Doubles in Four Years
The North American Pet Health Insurance Association (NAPHIA) announced that the pet insurance sector exceeded $2.83 B USD at year end 2021, and industry growth more than doubled over the past four years (2018 - 2021). NAPHIA’s 2022 State of the Industry Report shows a record $2.837 billion USD in total in-force premiums in 2021 (up over 30.5% from $2.175 billion USD in 2020) and over 4.41 million insured pets across North America (up 27.7% from over 3.45 million pets insured in 2020). - May 17, 2022 - NAPHIA - North American Pet Health Insurance Association
M&M Labs President and CEO Launches WellRabbit, a Physician-Vetted Supplement Website That Promotes Health and Wellness
The President and CEO of South Carolina and North Carolina-based M&M Labs, a physician-driven company that formulates, manufactures, and distributes nutraceutical products, is announcing the launch of a new supplement website. Dr. Jeffrey Hendricks is one of four founders of WellRabbit, an... - May 16, 2022 - WellRabbit
Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge
Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually. The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector. - May 13, 2022 - Intrinsica, Inc.
NuvOx Appoints Dr. Robert King to SAB
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Robert King to its Scientific Advisory Board (SAB). Dr. King is a seasoned life science executive with over 30 years’... - May 11, 2022 - NuvOx Pharma